☆Eagle Health Investments LP
Quality Q
0.381
AUM ($M)
603
Positions
27
Turnover
0.24
Top-10 wt
66%
Herfindahl
0.058
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 32 positions · portfolio value $603M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ARGX funds › | ARGENX SE | ADD | — | 11.8% | +0.0% | 70.9 | 76,417 | +81 | 5 | — |
| ☆ICLR funds › | ICON PUB LTD CO | TRIM | — | 8.9% | +0.5% | 53.5 | 308,143 | -50,357 | 5 | — |
| ☆GH funds › | GUARDANT HEALTH INC | TRIM | — | 7.5% | +1.5% | 45.1 | 300,685 | -9,596 | 5 | — |
| ☆INSM funds › | INSMED INC | ADD | — | 6.8% | -0.9% | 41.0 | 384,130 | +159,859 | 5 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | ADD | — | 5.9% | -0.1% | 35.7 | 624,676 | +118,867 | 5 | — |
| ☆ILMN funds › | ILLUMINA INC | HOLD | — | 5.5% | +0.6% | 33.0 | 187,413 | +0 | 5 | — |
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | ADD | — | 5.1% | -0.0% | 30.5 | 555,272 | +61,253 | 5 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | ADD | — | 5.0% | +1.1% | 30.4 | 248,322 | +69,000 | 3 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | HOLD | — | 4.9% | +1.0% | 29.5 | 884,121 | +0 | 2 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | HOLD | — | 4.8% | +2.4% | 29.2 | 2,060,427 | +0 | 4 | — |
| ☆ASND funds › | ASCENDIS PHARMA A/S | NEW | — | 4.7% | +4.7% | 28.3 | 106,158 | +106,158 | 1 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | ADD | — | 3.7% | +1.3% | 22.5 | 120,346 | +882 | 3 | — |
| ☆FTRE funds › | FORTREA HLDGS INC | TRIM | — | 3.4% | +0.8% | 20.6 | 1,181,274 | -126,286 | 4 | — |
| ☆KYMR funds › | KYMERA THERAPEUTICS INC | ADD | — | 3.2% | +0.6% | 19.1 | 166,148 | +20,332 | 3 | — |
| ☆AXSM funds › | AXSOME THERAPEUTICS INC. | NEW | — | 2.6% | +2.6% | 15.9 | 65,051 | +65,051 | 1 | — |
| ☆BSX funds › | BOSTON SCIENTIFIC CORP | ADD | — | 2.6% | -1.3% | 15.8 | 369,164 | +76,012 | 2 | — |
| ☆ALKS funds › | ALKERMES PLC | ADD | — | 2.6% | +0.8% | 15.6 | 297,302 | +58,629 | 4 | — |
| ☆IONS funds › | IONIS PHARMACEUTICALS INC | NEW | — | 2.6% | +2.6% | 15.4 | 194,577 | +194,577 | 1 | — |
| ☆TEM funds › | TEMPUS AI INC | HOLD | — | 2.5% | +0.0% | 14.8 | 256,269 | +0 | 2 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | NEW | — | 2.1% | +2.1% | 12.8 | 131,344 | +131,344 | 1 | — |
| ☆ATAI funds › | ATAIBECKLEY INC | HOLD | — | 1.5% | +0.2% | 9.0 | 1,709,359 | +0 | 2 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | NEW | — | 0.7% | +0.7% | 4.3 | 235,093 | +235,093 | 1 | — |
| ☆NTRA funds › | NATERA INC | TRIM | — | 0.7% | -4.4% | 4.3 | 15,847 | -106,030 | 5 | — |
| ☆LLY funds › | ELI LILLY & CO | NEW | — | 0.4% | +0.4% | 2.4 | 1,994 | +1,994 | 1 | — |
| ☆ISRG funds › | INTUITIVE SURGICAL INC | HOLD | — | 0.3% | -0.1% | 1.7 | 4,390 | +0 | 5 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | HOLD | — | 0.2% | -0.0% | 1.5 | 46,300 | +0 | 5 | — |
| ☆PCSC funds › | PERCEPTIVE CAP SOLUTIONS COR | HOLD | — | 0.1% | -0.0% | 0.4 | 37,686 | +0 | 2 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS PLC | EXIT | — | 0.0% | -1.8% | 0.0 | 0 | -214,291 | 0 | — |
| ☆PRCT funds › | PROCEPT BIOROBOTICS CORP | EXIT | — | 0.0% | -2.5% | 0.0 | 0 | -483,815 | 0 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | EXIT | — | 0.0% | -4.2% | 0.0 | 0 | -267,031 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.6% | 0.0 | 0 | -412,497 | 0 | — |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA A/S | EXIT | — | 0.0% | -4.2% | 0.0 | 0 | -86,650 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 603 | 27 | 0.24 | 66% | 0.058 | 0.380 | — | in |
| 2026Q1 | 476 | 26 | 0.27 | 64% | 0.056 | 0.286 | — | in |
| 2025Q4 | 455 | 30 | 0.24 | 71% | 0.062 | 0.352 | — | in |
| 2025Q3 | 381 | 23 | 0.16 | 76% | 0.073 | 0.548 | — | in |
| 2025Q2 | 405 | 21 | 0.17 | 74% | 0.068 | 0.572 | — | entered |
| 2025Q1 | 385 | 20 | 0.00 | 77% | 0.071 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status